AB
KRON

Amalgamated Bank’s Kronos Bio KRON Stock Holding History

Amalgamated Bank’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,131
Closed -$6K – 3080
2023
Q1 		$6K Sell
4,131
-943
-19% -$1.81K ﹤0.01% 2879
2022
Q4 		$8K Hold
5,074
– – ﹤0.01% 2898
2022
Q3 		$17K Hold
5,074
– – ﹤0.01% 2855
2022
Q2 		$18K Buy
5,074
+164
+3% +$743 ﹤0.01% 2878
2022
Q1 		$35K Buy
+4,910
New +$41.9K ﹤0.01% 2621

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Amalgamated Bank's KRON Position: Q2 2023 in Review

Amalgamated Bank sold out of Kronos Bio (KRON) in Q2 2023, closing a stake of 4,131 shares — an estimated $6K sold.

Amalgamated Bank first reported a position in KRON in Q1 2022 and held it in 5 quarters. The position peaked at $35K in Q1 2022. 80 funds tracked by Wall St. Rank hold KRON as of Q2 2023.

  • Amalgamated Bank reported no remaining Kronos Bio position as of Q2 2023 after selling out during the quarter.
  • Amalgamated Bank sold 4,131 Kronos Bio shares in Q2 2023, an estimated $6K.
  • Amalgamated Bank first reported a position in Kronos Bio in Q1 2022 and held it in 5 quarters.
  • Amalgamated Bank's Kronos Bio position peaked at $35K in Q1 2022.
  • 80 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2023.

Based on Amalgamated Bank's 13F filing for Q2 2023, filed 11 Aug 2023.